Eli Kalif

EVP & CFO, Teva Pharmaceutical

Search every verified Eli Kalif interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. On Teva's Q3 2021 earnings call, Eli Kalif reported that the company's net debt decreased to $21.7 billion from $22.7 billion in the prior quarter, attributing the reduction to free cash flow generation and exchange rate fluctuations. He noted the net debt-to-EBITDA ratio declined to 4.51 times, stating the company was making progress toward its 2023 target of being under three times by the end of 2022. Kalif also announced the launch of a $4 billion offering of sustainability-linked senior notes, describing it as a "debt neutral transaction" with proceeds expected to be used for refinancing existing debt. He stated that finance expenses were expected to remain around $1 billion in 2022.